Markets:

Overview

News

Currencies

International

Treasuries

ADMA Biologics Inc - Common Stock (NQ:ADMA)

16.38 -0.05 (-0.30%)

Streaming Delayed Price Updated: 9:37 AM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ADMA Biologics Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Earnings Outlook For ADMA Biologics ↗

March 22, 2023

Via Benzinga

ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023

March 16, 2023

Conference Call Scheduled for March 23, 2023, at 4:30 p.m. ET

From ADMA Biologics, Inc.

Via GlobeNewswire

7 A-Rated Penny Stocks Worth Betting On ↗

February 19, 2023

Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance.

Via InvestorPlace

7 A-Rated Healthcare Stocks to Buy for the Future of Medicine ↗

February 12, 2023

Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio.

Via InvestorPlace

Looking Into ADMA Biologics's Return On Capital Employed ↗

December 15, 2022

Via Benzinga

Recap: ADMA Biologics Q2 Earnings ↗

August 10, 2022

ADMA Biologics (NASDAQ:ADMA) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA

February 08, 2023

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance

January 17, 2023

From ADMA Biologics, Inc.

Via GlobeNewswire

Jim Cramer Says Forget AT&T, This 'Class Of The Field' Communications Stock Is Better ↗

January 10, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said ADMA Biologics, Inc. (NASDAQ: ADMA) is a "great spec, but it is losing money hand over fist. I think it’s very binary.

Via Benzinga

Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022 ↗

December 31, 2022

2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like...

Via Benzinga

ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®

December 13, 2022

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA Biologics Announces Closing of $69 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

December 09, 2022

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock

December 07, 2022

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA Biologics Announces Proposed Public Offering of Common Stock

December 06, 2022

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA Biologics Announces Preliminary Fourth Quarter 2022 Revenue Estimate

December 06, 2022

Fourth Quarter 2022 Preliminary Estimated Total Revenues of Approximately $48-$50 Million

From ADMA Biologics, Inc.

Via GlobeNewswire

Why Cano Health Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket ↗

November 10, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 59% to $0.1619 in pre-market trading after dipping 40% on Wednesday. Fast Radius recently filed voluntary petitions for relief under Chapter 11.

Via Benzinga

Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗

November 11, 2022

Gainers

Via Benzinga

Why Magnite Shares Are Trading Higher By Over 45%? Here Are 69 Stocks Moving In Thursday's Mid-Day Session ↗

November 10, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 10, 2022

Gainers NexImmune (NASDAQ:NEXI) shares rose 38.8% to $0.7 during Thursday's pre-market session. The market value of their outstanding shares is at $16.9 million.

Via Benzinga

Coupang, Rivian Automotive And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

November 10, 2022

U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

ADMA Biologics Announces Third Quarter 2022 Financial Results and Provides Business Update

November 09, 2022

From ADMA Biologics, Inc.

Via GlobeNewswire

A Preview Of ADMA Biologics's Earnings ↗

November 08, 2022

ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that ADMA...

Via Benzinga

ADMA Biologics to Report Third Quarter 2022 Financial Results on November 9, 2022

November 02, 2022

From ADMA Biologics, Inc.

Via GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC

October 31, 2022

From ADMA Biologics, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗

October 13, 2022

Upgrades

Via Benzinga

7 A-Rated Stocks to Buy for Less Than $10 ↗

September 23, 2022

While stocks under $10 don't carry the cache of blue-chip stocks, the returns that they offer can be enticing.

Via InvestorPlace

7 Top-Rated Biotech Stocks to Buy for Q4 ↗

September 15, 2022

A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 02, 2022

Via Benzinga

Stocks That Made New Highs On Friday, Aug. 19 ↗

August 21, 2022

On Friday, in spite of the stock market being down, there were several stocks that actually made new highs.

Via Talk Markets

ADMA Biologics: Earnings Outlook ↗

August 09, 2022

ADMA Biologics (NASDAQ:ADMA) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement. Analysts estimate that ADMA...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.